Drug Type Small molecule drug |
Synonyms AZ-1495 |
Target |
Action inhibitors |
Mechanism IRAK4 inhibitors(Interleukin-1 receptor-associated kinase 4 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Central Nervous System Neoplasms | Preclinical | United States | - | |
Central Nervous System Neoplasms | Preclinical | United States | - | |
Central Nervous System Neoplasms | Preclinical | Canada | - | |
Lymphoma | Preclinical | United States | - | |
Lymphoma | Preclinical | United States | - | |
Lymphoma | Preclinical | Canada | - |